Ceftiofur-resistant Salmonella strains isolated from dairy farms represent multiple widely distributed subtypes that evolved by independent horizontal gene transfer.
Salmonella is the leading cause of known food-borne bacterial infections in the United States, with an incidence rate of approximately 15 cases per 100,000 people. The rise of antimicrobial-resistant Salmonella subtypes, including the appearance of subtypes resistant to ceftriaxone, represents a particular concern. Ceftriaxone is used to treat invasive cases of Salmonella in children and is closely related to ceftiofur, an antibiotic commonly used to treat diseases of cattle. In order to develop a better understanding of the evolution and transmission of ceftiofur resistance in Salmonella, we characterized ceftiofur-resistant and -sensitive Salmonella isolates from seven New York dairy farms. A total of 39 isolates from these seven farms were analyzed for evolutionary relatedness (by DNA sequencing of the Salmonella genes fimA, manB, and mdh), antibiotic resistance profiles, and the presence of bla(CMY-2), a beta-lactamase gene associated with resistance to cephalosporins. Our data indicate that (i) resistance to ceftriaxone and ceftiofur was highly correlated with the presence of bla(CMY-2); (ii) ceftiofur-resistant Salmonella strains were geographically widespread, as shown by their isolation from farms located throughout New York State; (iii) ceftiofur-resistant Salmonella strains isolated from farms represent multiple distinct subtypes and evolutionary lineages, as determined by serotyping, DNA sequence typing, and antimicrobial-resistance profiles; and (iv) ceftiofur-resistant Salmonella strains evolved by multiple independent acquisitions of an identical bla(CMY-2) allele and by clonal spread of ceftiofur-resistant subtypes.
Alcaine
S D
SD
Department of Food Science, Cornell University, Ithaca, NY 14853, USA.
Sukhnanand
S S
SS
Warnick
L D
LD
Su
W-L
WL
McGann
P
P
McDonough
P
P
Wiedmann
M
M
D000483:Alleles; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002417:Cattle; D002443:Ceftriaxone / Q000627:therapeutic use; D018550:Cephalosporin Resistance; D002511:Cephalosporins / Q000627:therapeutic use*; D002999:Clone Cells; D003612:Dairying; D024881:Drug Resistance, Bacterial; D018432:Drug Resistance, Multiple; D017753:Ecosystem; D019143:Evolution, Molecular; D022761:Gene Transfer, Horizontal; D005798:Genes, Bacterial; D009518:New York / Q000453:epidemiology; D010802:Phylogeny; D012475:Salmonella / Q000235:genetics* / Q000302:isolation & purification; D012481:Salmonella Infections, Animal / Q000453:epidemiology / Q000378:metabolism* / Q000382:microbiology / Q000635:transmission; D017422:Sequence Analysis, DNA; D012698:Serologic Tests; D001618:beta-Lactamases / Q000235:genetics / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002443:Ceftriaxone; C053503:ceftiofur; D001618:beta-Lactamases